Suchergebnisse - "Lipka, Daniel B"

PubPharm (5)

1

Differential roles of STAT1 and STAT2 in the sensitivity of JAK2V617F- vs. BCR-ABL-positive cells to interferon alpha

enthalten in: Journal of hematology & oncology | 2019

von Schubert, C. | Allhoff, M. | Tillmann, S. | +9

2

Intracellular retention of ABL kinase inhibitors determines commitment to apoptosis in CML cells

enthalten in: PloS one | 2012

von Lipka, D. | Wagner, M. | Dziadosz, M. | +8

3

Wild-type JAK2 secondary acute erythroleukemia developing after JAK2-V617F-mutated primary myelofibrosis

enthalten in: Acta haematologica | 2009

von Kreft, A. | Springer, E. | Lipka, D. | +1

4

LS104, a non-ATP-competitive small-molecule inhibitor of JAK2, is potently inducing apoptosis in JAK2V617F-positive cells

enthalten in: Molecular cancer therapeutics | 2008

von Lipka, D. | Hoffmann, L. | Heidel, F. | +8

5

Rare occurrence of the JAK2 V617F mutation in AML subtypes M5, M6, and M7

enthalten in: Blood | 2006

von Fröhling, S. | Lipka, D. | Kayser, S. | +6

1
[1]